-
1
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
-
1:CAS:528:DyaK2sXlsFKksLY%3D 9196156
-
Burris HA III, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
-
(1997)
J Clin Oncol
, vol.15
, pp. 2403-2413
-
-
Burris III, H.A.1
Moore, M.J.2
Andersen, J.3
-
2
-
-
33845953092
-
Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair
-
1:CAS:528:DC%2BD28XhtFegsbrJ 16920718 10.1074/jbc.M603678200
-
Bentle MS, Reinicke KE, Bey EA, Spitz DR, Boothman DA (2006) Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair. J Biol Chem 281:33684-33696
-
(2006)
J Biol Chem
, vol.281
, pp. 33684-33696
-
-
Bentle, M.S.1
Reinicke, K.E.2
Bey, E.A.3
Spitz, D.R.4
Boothman, D.A.5
-
3
-
-
34547481318
-
An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone
-
1:CAS:528:DC%2BD2sXotVakt74%3D 1913860 17609380 10.1073/pnas.0702176104
-
Bey EA, Bentle MS, Reinicke KE et al (2007) An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci U S A 104:11832-11837
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 11832-11837
-
-
Bey, E.A.1
Bentle, M.S.2
Reinicke, K.E.3
-
4
-
-
0035374621
-
Calcium is a key signaling molecule in beta-lapachone-mediated cell death
-
1:CAS:528:DC%2BD3MXkt12rs7w%3D 11279125 10.1074/jbc.M100730200
-
Tagliarino C, Pink JJ, Dubyak GR, Nieminen AL, Boothman DA (2001) Calcium is a key signaling molecule in beta-lapachone-mediated cell death. J Biol Chem 276:19150-19159
-
(2001)
J Biol Chem
, vol.276
, pp. 19150-19159
-
-
Tagliarino, C.1
Pink, J.J.2
Dubyak, G.R.3
Nieminen, A.L.4
Boothman, D.A.5
-
5
-
-
0037978371
-
Inhibition of radiation-induced neoplastic transformation by beta-lapachone
-
1:CAS:528:DyaL1MXksleqtrk%3D 297536 2740334 10.1073/pnas.86.13.4963
-
Boothman DA, Pardee AB (1989) Inhibition of radiation-induced neoplastic transformation by beta-lapachone. Proc Natl Acad Sci U S A 86:4963-4967
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 4963-4967
-
-
Boothman, D.A.1
Pardee, A.B.2
-
6
-
-
33748485131
-
High incidence of EMMPRIN expression in human tumors
-
1:CAS:528:DC%2BD28Xps1Sns7s%3D 16721788 10.1002/ijc.22062
-
Riethdorf S, Reimers N, Assmann V et al (2006) High incidence of EMMPRIN expression in human tumors. Int J Cancer 119:1800-1810
-
(2006)
Int J Cancer
, vol.119
, pp. 1800-1810
-
-
Riethdorf, S.1
Reimers, N.2
Assmann, V.3
-
7
-
-
0036943814
-
EMMPRIN-mediated MMP regulation in tumor and endothelial cells
-
1:CAS:528:DC%2BD38Xpt1KqtbY%3D 12553375 10.1023/A:1021350718226
-
Caudroy S, Polette M, Nawrocki-Raby B et al (2002) EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 19:697-702
-
(2002)
Clin Exp Metastasis
, vol.19
, pp. 697-702
-
-
Caudroy, S.1
Polette, M.2
Nawrocki-Raby, B.3
-
8
-
-
33744962429
-
Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium
-
1:CAS:528:DC%2BD28XlvVCgt7w%3D 16522689 10.1210/jc.2005-0601
-
Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowak RA (2006) Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. J Clin Endocrinol Metab 91:2358-2365
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2358-2365
-
-
Braundmeier, A.G.1
Fazleabas, A.T.2
Lessey, B.A.3
Guo, H.4
Toole, B.P.5
Nowak, R.A.6
-
9
-
-
0033998456
-
Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: Correlation with invasive growth of breast cancer
-
1:STN:280:DC%2BD3c7is1Cgsw%3D%3D 10658069 10.1007/s002689910053
-
Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M (2000) Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg 24:334-340
-
(2000)
World J Surg
, vol.24
, pp. 334-340
-
-
Dalberg, K.1
Eriksson, E.2
Enberg, U.3
Kjellman, M.4
Backdahl, M.5
-
10
-
-
0033991191
-
Role of MT-MMPs and MMP-2 in pancreatic cancer progression
-
1:CAS:528:DC%2BD3cXhsVaitQ%3D%3D 10585576 10.1002/(SICI)1097- 0215(20000101)85:1<14: AID-IJC3>3.0.CO;2-O
-
Ellenrieder V, Alber B, Lacher U et al (2000) Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer 85:14-20
-
(2000)
Int J Cancer
, vol.85
, pp. 14-20
-
-
Ellenrieder, V.1
Alber, B.2
Lacher, U.3
-
11
-
-
76249112702
-
EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
-
1:CAS:528:DC%2BC3cXhtFeisA%3D%3D 19837976 10.1182/blood-2009-04-217380
-
Bougatef F, Quemener C, Kellouche S et al (2009) EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood 114:5547-5556
-
(2009)
Blood
, vol.114
, pp. 5547-5556
-
-
Bougatef, F.1
Quemener, C.2
Kellouche, S.3
-
12
-
-
0034796595
-
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
-
1:CAS:528:DC%2BD3MXmvFOmsrc%3D 11533692 10.1038/nm0901-987
-
Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987-989
-
(2001)
Nat Med
, vol.7
, pp. 987-989
-
-
Jain, R.K.1
-
13
-
-
79955003047
-
Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging
-
1:CAS:528:DC%2BC3MXovFOiur4%3D 21496446
-
Kim H, Folks KD, Guo L et al (2011) Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging. Mol Imaging 10:153-167
-
(2011)
Mol Imaging
, vol.10
, pp. 153-167
-
-
Kim, H.1
Folks, K.D.2
Guo, L.3
-
14
-
-
34248594167
-
Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts
-
17401098 10.2967/jnumed.106.036608
-
Dandekar M, Tseng JR, Gambhir SS (2007) Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts. J Nucl Med 48:602-607
-
(2007)
J Nucl Med
, vol.48
, pp. 602-607
-
-
Dandekar, M.1
Tseng, J.R.2
Gambhir, S.S.3
-
15
-
-
0346562891
-
Positron emission tomography using 2-deoxy-2-[18F]-fluoro-d-glucose for response monitoring in locally advanced gastroesophageal cancer; A comparison of different analytical methods
-
14630513 10.1016/j.mibio.2003.09.007
-
Kroep JR, Van Groeningen CJ, Cuesta MA et al (2003) Positron emission tomography using 2-deoxy-2-[18F]-fluoro-d-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. Mol Imaging Biol 5:337-346
-
(2003)
Mol Imaging Biol
, vol.5
, pp. 337-346
-
-
Kroep, J.R.1
Van Groeningen, C.J.2
Cuesta, M.A.3
-
16
-
-
20244376908
-
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
-
1:CAS:528:DC%2BD2MXjtlejsbY%3D 15837727 10.1158/1078-0432.CCR-04-2626
-
Kelloff GJ, Hoffman JM, Johnson B et al (2005) Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 11:2785-2808
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2785-2808
-
-
Kelloff, G.J.1
Hoffman, J.M.2
Johnson, B.3
-
17
-
-
79551595372
-
DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy
-
20383593 10.1007/s11307-010-0320-2
-
Kim H, Folks KD, Guo L et al (2011) DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Mol Imaging Biol 13:94-103
-
(2011)
Mol Imaging Biol
, vol.13
, pp. 94-103
-
-
Kim, H.1
Folks, K.D.2
Guo, L.3
-
18
-
-
0031969264
-
Angiogenesis and tumor metastasis
-
1:CAS:528:DyaK1cXhtFKqt70%3D 9509272 10.1146/annurev.med.49.1.407
-
Zetter BR (1998) Angiogenesis and tumor metastasis. Annu Rev Med 49:407-424
-
(1998)
Annu Rev Med
, vol.49
, pp. 407-424
-
-
Zetter, B.R.1
-
19
-
-
84861479808
-
(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts
-
3594775 21494920 10.1007/s11307-011-0491-5 MIB: the official publication of the Academy of Molecular Imaging
-
Shah N, Zhai G, Knowles JA et al (2012) (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol 14:237-244, MIB: the official publication of the Academy of Molecular Imaging
-
(2012)
Mol Imaging Biol
, vol.14
, pp. 237-244
-
-
Shah, N.1
Zhai, G.2
Knowles, J.A.3
-
20
-
-
80052532390
-
Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy
-
1:CAS:528:DC%2BC3MXhtVyltbbO 3587034 21730821 10.1097/CAD. 0b013e328349311e
-
Kim H, Zhai G, Liu Z et al (2011) Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anti-Cancer Drugs 22:864-874
-
(2011)
Anti-Cancer Drugs
, vol.22
, pp. 864-874
-
-
Kim, H.1
Zhai, G.2
Liu, Z.3
-
21
-
-
51549089094
-
Breast tumor xenografts: Diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody
-
18710978 10.1148/radiol.2483071740
-
Kim H, Morgan DE, Zeng H et al (2008) Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology 248:844-851
-
(2008)
Radiology
, vol.248
, pp. 844-851
-
-
Kim, H.1
Morgan, D.E.2
Zeng, H.3
-
22
-
-
0003973174
-
-
The McGraw-Hill Companies, Inc. Columbus
-
Neter J, Kutner MH, Nachtsheim JC, Wasserman W (1996) Applied linear statistical models. The McGraw-Hill Companies, Inc., Columbus
-
(1996)
Applied Linear Statistical Models
-
-
Neter, J.1
Kutner, M.H.2
Nachtsheim, J.C.3
Wasserman, W.4
-
23
-
-
0022107328
-
Repeated-measures analysis of variance in developmental research: Selected issues
-
1:STN:280:DyaL28%2FgtlOisw%3D%3D 4042744 10.2307/1130092
-
Hertzog C, Rovine M (1985) Repeated-measures analysis of variance in developmental research: selected issues. Child Dev 56:787-809
-
(1985)
Child Dev
, vol.56
, pp. 787-809
-
-
Hertzog, C.1
Rovine, M.2
-
24
-
-
84952503562
-
Thirteen ways to look at the correlation coefficient
-
10.2307/2685263
-
Rodgers JL, Nicewander WA (1988) Thirteen ways to look at the correlation coefficient. Am Stat 42:59-66
-
(1988)
Am Stat
, vol.42
, pp. 59-66
-
-
Rodgers, J.L.1
Nicewander, W.A.2
-
25
-
-
84863156565
-
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma
-
1:CAS:528:DC%2BC38XitFWlu70%3D 3277644 22203731 10.1158/1535-7163.MCT-11- 0581
-
Kim H, Zhai G, Samuel SL et al (2012) Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma. Mol Cancer Ther 11:405-415
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 405-415
-
-
Kim, H.1
Zhai, G.2
Samuel, S.L.3
-
26
-
-
0042706306
-
Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics
-
12884330 10.1002/jmri.10337 JMRI
-
Danet IM, Semelka RC, Nagase LL, Woosely JT, Leonardou P, Armao D (2003) Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics. J Magn Reson Imaging 18:181-188, JMRI
-
(2003)
J Magn Reson Imaging
, vol.18
, pp. 181-188
-
-
Danet, I.M.1
Semelka, R.C.2
Nagase, L.L.3
Woosely, J.T.4
Leonardou, P.5
Armao, D.6
-
27
-
-
20444479863
-
Differential diagnosis of pancreatic tumors using ultrasound contrast imaging
-
15942718 10.1007/s00535-005-1578-z
-
Sofuni A, Iijima H, Moriyasu F et al (2005) Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 40:518-525
-
(2005)
J Gastroenterol
, vol.40
, pp. 518-525
-
-
Sofuni, A.1
Iijima, H.2
Moriyasu, F.3
-
28
-
-
1642266635
-
Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma
-
1:STN:280:DC%2BD1c7ntlyhtw%3D%3D 2020655 18333037 10.1080/ 13651820310017093 The Official Journal of the International Hepato Pancreato Biliary Association
-
Andersson R, Vagianos CE, Williamson RC (2004) Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma. HPB 6:5-12, The Official Journal of the International Hepato Pancreato Biliary Association
-
(2004)
HPB
, vol.6
, pp. 5-12
-
-
Andersson, R.1
Vagianos, C.E.2
Williamson, R.C.3
-
29
-
-
22844445593
-
Locally advanced pancreatic cancer
-
16002845 10.1200/JCO.2005.23.911 Official Journal of the American Society of Clinical Oncology
-
Willett CG, Czito BG, Bendell JC, Ryan DP (2005) Locally advanced pancreatic cancer. J Clin Oncol 23:4538-4544, Official Journal of the American Society of Clinical Oncology
-
(2005)
J Clin Oncol
, vol.23
, pp. 4538-4544
-
-
Willett, C.G.1
Czito, B.G.2
Bendell, J.C.3
Ryan, D.P.4
-
30
-
-
33745649188
-
Locally advanced pancreatic cancer: Current therapeutic approach
-
1:CAS:528:DC%2BD28XhtFGhu7vE 16794240 10.1634/theoncologist.11-6-612
-
Cardenes HR, Chiorean EG, Dewitt J, Schmidt M, Loehrer P (2006) Locally advanced pancreatic cancer: current therapeutic approach. Oncologist 11:612-623
-
(2006)
Oncologist
, vol.11
, pp. 612-623
-
-
Cardenes, H.R.1
Chiorean, E.G.2
Dewitt, J.3
Schmidt, M.4
Loehrer, P.5
-
31
-
-
84864272568
-
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
-
22517425 10.1002/jmri.23660 JMRI
-
Chang YC, Yu CJ, Chen CM et al (2012) Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin. J Magn Reson Imaging 36:387-396, JMRI
-
(2012)
J Magn Reson Imaging
, vol.36
, pp. 387-396
-
-
Chang, Y.C.1
Yu, C.J.2
Chen, C.M.3
-
32
-
-
84869866354
-
Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: Potential of whole tumour ROI and selective ROI analysis
-
22944331 10.1016/j.ejrad.2012.07.022
-
Coenegrachts K, Bols A, Haspeslagh M, Rigauts H (2012) Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: potential of whole tumour ROI and selective ROI analysis. Eur J Radiol 81:3870-3876
-
(2012)
Eur J Radiol
, vol.81
, pp. 3870-3876
-
-
Coenegrachts, K.1
Bols, A.2
Haspeslagh, M.3
Rigauts, H.4
-
33
-
-
77951222660
-
Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI
-
19727758 10.1007/s00330-009-1556-6
-
Zwick S, Brix G, Tofts PS et al (2010) Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. Eur Radiol 20:432-442
-
(2010)
Eur Radiol
, vol.20
, pp. 432-442
-
-
Zwick, S.1
Brix, G.2
Tofts, P.S.3
-
34
-
-
84874293321
-
Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions
-
23220897 10.1148/radiol.12120278
-
Heye T, Davenport MS, Horvath JJ et al (2013) Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions. Radiology 266:801-811
-
(2013)
Radiology
, vol.266
, pp. 801-811
-
-
Heye, T.1
Davenport, M.S.2
Horvath, J.J.3
-
35
-
-
84862566809
-
An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis
-
1:CAS:528:DC%2BC38Xos1yisr4%3D 22532167 10.1158/0008-5472.CAN-11-3135
-
Huang X, Dong Y, Bey EA et al (2012) An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis. Cancer Res 72:3038-3047
-
(2012)
Cancer Res
, vol.72
, pp. 3038-3047
-
-
Huang, X.1
Dong, Y.2
Bey, E.A.3
|